Bcr-Abl DNA vaccine expressing GM-CSF and IL-12 (Mologen)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameBcr-Abl DNA vaccine expressing GM-CSF and IL-12 (Mologen)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionBcr-Abl tyrosine kinase modulatorsGranulocyte-macrophage colony-stimulating factor receptor stimulantsInterleukin-12 receptor stimulants

TargetsGranulocyte-macrophage colony-stimulating factor receptorBcr-Abl tyrosine kinaseInterleukin-12 receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryWorld

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMologen Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMologen Ag

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A